ArticleEcancermedicalscience2022

The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time.

Felipe Andrés Cordero da Luz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.